174 related articles for article (PubMed ID: 5481776)
1. Stimulation of human-growth-hormone secretion by L-dopa.
Boyd AE; Lebovitz HE; Pfeiffer JB
N Engl J Med; 1970 Dec; 283(26):1425-9. PubMed ID: 5481776
[No Abstract] [Full Text] [Related]
2. Amantadine enhancement of L-DOPA induced growth hormone stimulation.
Massara F; Camanni F; Molinatti GM
Horm Metab Res; 1973 Nov; 5(6):454-6. PubMed ID: 4767002
[No Abstract] [Full Text] [Related]
3. Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
Imura H; Nakai Y; Matsukura S; Matsuyama H
Horm Metab Res; 1973 Jan; 5(1):41-5. PubMed ID: 4706921
[No Abstract] [Full Text] [Related]
4. Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.
Malarkey WB; Cyrus J; Paulson GW
J Clin Endocrinol Metab; 1974 Aug; 39(2):229-35. PubMed ID: 4371345
[No Abstract] [Full Text] [Related]
5. Effects of L-dopa on plasma growth hormones and insulin.
Kytomaki O; Nousiainen R; Pekkarinen A; Rinne U; Siirtola T; Sonninen V; Viljanen M
Acta Neurol Scand Suppl; 1972; 51():125-6. PubMed ID: 4514338
[No Abstract] [Full Text] [Related]
6. [Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
Sakoda M; Kusaka T; Baba S; Shirakata S
Nihon Naibunpi Gakkai Zasshi; 1972 Jul; 48(4):241-4. PubMed ID: 5066290
[No Abstract] [Full Text] [Related]
7. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
Kansal PC; Buse J; Talbert OR; Buse MG
J Clin Endocrinol Metab; 1972 Jan; 34(1):99-105. PubMed ID: 5061778
[No Abstract] [Full Text] [Related]
8. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
Sirtori CR; Bolme P; Azarnoff DL
N Engl J Med; 1972 Oct; 287(15):729-33. PubMed ID: 5056733
[No Abstract] [Full Text] [Related]
9. Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients.
Cavagnini F; Peracchi M; Scotti G; Raggi U; Pontiroli AE; Bana R
J Endocrinol; 1972 Sep; 54(3):425-33. PubMed ID: 5071365
[No Abstract] [Full Text] [Related]
10. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
Cavagnini F; Pontiroli AE; Raggi U; Peracchi M; Malinverni A
Folia Endocrinol; 1973 Dec; 26(6):483-9. PubMed ID: 4801258
[No Abstract] [Full Text] [Related]
11. [Effect of L-dopa on pituitary hormones and on carbohydrate and fat metabolism in normal persons and in patients with Parkinsonism].
Geser CA; Müller-Hess R; Dufresne JJ; Felber JP; Vannotti A
Schweiz Med Wochenschr; 1973 May; 103(19):690-7. PubMed ID: 4703913
[No Abstract] [Full Text] [Related]
12. Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
Perlow MJ; Sassin JF; Boyar R; Hellman L; Weitzman ED
Dis Nerv Syst; 1972 Dec; 33(12):804-10. PubMed ID: 4668972
[No Abstract] [Full Text] [Related]
13. [Serum gonadotropic level under the medication L-dopa].
Janzik HH; Heller S
Arzneimittelforschung; 1974 Aug; 24(8):1084-5. PubMed ID: 4479602
[No Abstract] [Full Text] [Related]
14. [Growth hormone stimulation with L. Dopa].
Elkaïm R; Halimi S; Guidicelli C; Agnius-Delord C; Hadjian A; Perret J; Micoud M
Nouv Presse Med; 1972 Mar; 1(10):675-7. PubMed ID: 4553974
[No Abstract] [Full Text] [Related]
15. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
Knutsson E; Mårtensson A
Scand J Rehabil Med; 1974; 6(2):89-93. PubMed ID: 4837060
[No Abstract] [Full Text] [Related]
16. Effect of L-dopa on plasma free fatty acids and plasma glucose.
Rivera-Calimlim L; Bianchine JR
Metabolism; 1972 Jul; 21(7):611-7. PubMed ID: 5040916
[No Abstract] [Full Text] [Related]
17. Glucose-suppressible growth hormone release after L-dopa administration to normal subjects.
Johansen K
Metabolism; 1973 Jun; 22(6):773-8. PubMed ID: 4709329
[No Abstract] [Full Text] [Related]
18. L-DOPA and pituitary hormone secretion.
Hayek A; Crawford JD
J Clin Endocrinol Metab; 1972 May; 34(5):764-6. PubMed ID: 5012491
[No Abstract] [Full Text] [Related]
19. [10 years of L-DOPA therapy of Parkinson's syndrome].
Birkmayer W
Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
[No Abstract] [Full Text] [Related]
20. Plasma growth hormone and insulin response to levodopa and amantadine.
Kytömäki O; Nousiainen R; Pekkarinen A; Rinne UK; Viljanen M
J Neural Transm; 1973; 34(2):145-51. PubMed ID: 4722572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
